BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35927969)

  • 1. Challenges in the interpretation of a germline TERT variant in a patient with juvenile myelomonocytic leukemia.
    Janczar S; Kirschner M; Beier F; Brümmendorf TH; Ussowicz M; Babol-Pokora K; Oszer A; Yoshimi A; Kalwak K; Mlynarski W
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29909. PubMed ID: 35927969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
    Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia.
    Aspesi A; Vallero S; Rocci A; Pavesi E; Lanciotti M; Ramenghi U; Dianzani I
    Pediatr Blood Cancer; 2010 Sep; 55(3):550-3. PubMed ID: 20658629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
    Gramatges MM; Bertuch AA
    Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita.
    Vulliamy T; Dokal I
    Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spectrum of severe familial liver disorders associate with telomerase mutations.
    Calado RT; Regal JA; Kleiner DE; Schrump DS; Peterson NR; Pons V; Chanock SJ; Lansdorp PM; Young NS
    PLoS One; 2009 Nov; 4(11):e7926. PubMed ID: 19936245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita and telomere biology disorders.
    Savage SA
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the understanding of dyskeratosis congenita.
    Walne AJ; Dokal I
    Br J Haematol; 2009 Apr; 145(2):164-72. PubMed ID: 19208095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
    Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
    Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
    Dokal I; Vulliamy T
    Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of telomere biology disorders.
    Grill S; Nandakumar J
    J Biol Chem; 2021; 296():100064. PubMed ID: 33482595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.